Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Isotype | IgG1, kappa |
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Isatuximab Biosimilar - Anti-CD38 mAb - Research Grade |
---|---|
Source | CAS 1461640-62-9 |
Species | Chimeric |
Purity | >85% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Aliases /Synonyms | Isatuximab,SAR-650984,hu38SB19,CD38,anti-CD38 |
Reference | PX-TA1377 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG1-kappa |
Clonality | Monoclonal Antibody |
Isatuximab is a humanized monoclonal antibody derived from IgG1 that targets CD38, a glycoprotein found on the surface of some immune cells. CD38 is highly expressed by malignant plasma cells in multiple myeloma. Isatuximab is used to treat multiple myeloma. It is marketed under the trade name Sarclisa.
Isatuximab Biosimilar - Anti-CD38 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Immobilized CD38 Recombinant Protein (cat. No.PX-P4081) at 0.5µg/mL (100µL/well) can bind to Isatuximab Biosimilar - Anti-CD38 mAb (cat. No.PX-TA1377) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Send us a message from the form below
Your cart is currently empty.
View Products
Reviews
There are no reviews yet.